Related Experiment Video

Updated: Jun 22, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Matrix metalloproteinases and cardiovascular diseases

A Papazafiropoulou1, N Tentolouris

  • 1Department of Propaedeutic Medicine, Laiko Hospital, Athens University Medical School, Athens, Greece. pathan@ath.forethnet.gr

Hippokratia
|June 30, 2009
PubMed

Insights

Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are key in cardiovascular diseases like atherosclerosis. Medications such as statins and antihypertensives may affect MMPs activity, influencing disease progression.

Area of Science:

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are extracellular enzymes crucial for physiological and pathological processes.
  • Tissue inhibitors of metalloproteinases (TIMPs) are the primary regulators of MMPs activity.
  • MMP expression is linked to cardiovascular risk factors and inflammation.

Purpose of the Study:

  • To review the existing literature on the role of MMPs and TIMPs in cardiovascular diseases.
  • To explore the influence of common cardiovascular medications on MMPs activity.

Main Methods:

  • Literature review of studies investigating MMPs, TIMPs, and cardiovascular disease.
  • Analysis of research on the effects of antihypertensives, glitazones, and statins on MMPs.

Main Results:

  • MMPs are implicated in key cardiovascular conditions including atherosclerosis, plaque formation, and acute coronary syndrome.
  • Inflammation and cardiovascular risk factors are associated with altered MMPs expression.
  • Certain medications, including statins and antihypertensives, may modulate MMPs activity.

Conclusions:

  • MMPs and TIMPs are significant factors in the pathogenesis of cardiovascular disease.
  • Understanding the interplay between MMPs, inhibitors, and medications is vital for cardiovascular health management.
Keywords:
acute coronary syndromesaneurysmsatherosclerosisextracellular matrixmetalloproteinases

More Related Videos

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels07:39

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels

Published on: January 22, 2019

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...